Evaluate the Efficacy and Safety of TQC2731 Injection in Patients With Severe Asthma.

NCT05472324 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

205

Enrollment

INDUSTRY

Sponsor class

Conditions

Severe Asthma

Interventions

DRUG: TQC2731 injection
DRUG: Placebo

Sponsor

Chia Tai Tianqing Pharmaceutical Group Co., Ltd.